Detalhe da pesquisa
1.
Clinical Significance of Perineural Invasion in Men With Grade Group 1 Prostate Cancer on Active Surveillance.
J Urol
; 209(1): 180-186, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36073925
2.
Identifying Men Who Can Remain on Active Surveillance Despite Biopsy Reclassification to Grade Group 2 Prostate Cancer.
J Urol
; 210(1): 99-107, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37042826
3.
Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients.
Prostate
; 81(10): 703-709, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33956350
4.
Transperineal Prostate Biopsy Improves the Detection of Clinically Significant Prostate Cancer among Men on Active Surveillance.
J Urol
; 205(4): 1069-1074, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33487007
5.
Utility of multiparametric magnetic resonance imaging in the risk stratification of men with Grade Group 1 prostate cancer on active surveillance.
BJU Int
; 125(6): 861-866, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32039537
6.
Development and Validation of the False Disorder Score: The Focal Scale of the Inventory of Problems.
J Pers Assess
; 101(6): 653-661, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30388903
7.
Comparison of Biochemical Recurrence-Free Survival after Radical Prostatectomy Triggered by Grade Reclassification during Active Surveillance and in Men Newly Diagnosed with Similar Grade Disease.
J Urol
; 198(3): 608-613, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28347771
8.
Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillance.
BJU Int
; 120(1): 25-31, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27469419
9.
The Development of the Inventory of Problems-29: A Brief Self-Administered Measure for Discriminating Bona Fide From Feigned Psychiatric and Cognitive Complaints.
J Pers Assess
; 99(5): 534-544, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27767344
10.
Conditional probability of reclassification in an active surveillance program for prostate cancer.
J Urol
; 193(6): 1950-5, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25572035
11.
Fluoroquinolone resistance in the rectal carriage of men in an active surveillance cohort: longitudinal analysis.
J Urol
; 193(2): 552-6, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25111911
12.
Prostate specific antigen velocity risk count predicts biopsy reclassification for men with very low risk prostate cancer.
J Urol
; 191(3): 629-37, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24060641
13.
Serum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density.
BJU Int
; 113(4): 561-7, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23746233
14.
Expanded criteria to identify men eligible for active surveillance of low risk prostate cancer at Johns Hopkins: a preliminary analysis.
J Urol
; 190(6): 2033-8, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23680308
15.
Pathological outcomes in men with low risk and very low risk prostate cancer: implications on the practice of active surveillance.
J Urol
; 190(4): 1218-22, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23643603
16.
Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillance.
BJU Int
; 111(7): 1037-45, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23464904
17.
Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) Magnetic Resonance Imaging Scoring to Predict Clinical Outcomes in Active Surveillance for Grade Group 1 Prostate Cancer.
Urology
; 180: 194-199, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37536582
18.
Baseline prostate health index risk category and risk category changes during active surveillance predict grade reclassification.
Urol Oncol
; 41(11): 455.e1-455.e6, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37722985
19.
Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer.
J Urol
; 188(4): 1131-6, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22901577
20.
Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer.
BJU Int
; 110(5): 651-7, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22289613